Thrombotic thrombocytopenic purpura: 24 Years of experience at the American University of Beirut Medical Center

Journal of Clinical Apheresis

Volumn 19, Issue 3, 2004, Pages 119-124

  Shamseddine, Ali ^a   Saliba, Teddy ^a   Aoun, Elie ^a   Chahal, Aref ^a   El Saghir, Nagi ^a   Salem, Ziad ^a   Bazarbachi, Ali ^a   Khalil, Mazen ^a   Taher, Ali ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Lebanon; Plasma exchange; TTP

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; STEROID; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EXPERIENCE; FEMALE; FEVER; HUMAN; KIDNEY DISEASE; LEBANON; MALE; MEDICAL RECORD; MORTALITY; NEUROLOGIC DISEASE; PATIENT REFERRAL; PLASMAPHERESIS; RELAPSE; REMISSION; SPLENECTOMY; SYMPTOM; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES;

EID: 6344250961     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20004     Document Type: Article

References (37)

1. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924;24:21-24.
2. Singer K, Bornstein F, Wiles A. thrombotic thrombocytopenic purpura. Blood 1947;2:542-554.
3. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
4. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
5. Moake J. Thrombotic thrombocytopenic purpura: the systemic clumping. Annu Rev Med 2002;53:75-88.
6. Torok TJ, Holman RC, Chorba TL. Increasing mortality from thrombotic thrombocytopenic purpura in the United States: analysis of national mortality data, 1968-1991. Am J Hematol 1995;50:84-90.
7. Sarode R, Gottschall JL, Aster RH, McFarland JG. Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 1997;54:102-107.
8. McCarthy LJ, Danielson CF, Skipworth EM, Peters SL, Miraglia CC, Antony AC. Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience. Ther Apheresis 2002;6:2-4.
9. Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol 1986;15:413-442.
10. Moake JL, Byrnes JJ. Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 1996;10:485-497.
11. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994;24: 175-172.
12. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL. Antibody inhibitors to von Willebrand factor metalloproteinase and increased von Willebrand factor-platelet binding in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Int Med 2000;132:794-799.
13. Bennett CL, Connors JM, Carwile JM, Moake JL, Bell WR, Tarantolo SR, McCarthy LJ, Sarode R, Hatfield AJ, Feldman MD. Thrombotic thrombocytopenic purpura associated with clopidogrel. New Engl J Med 2000;342:1773-1777.
14. Rabadi SJ, Khandekar JD, Miller HJ. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of the literature. Cancer Treat Rep 1982;66:1244-1247.
15. Atkinson K, Biggs JC, Hayes J, Ralston M, Dodds AJ, Concannon AJ, Naidoo D. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 1983;54:59-67.
16. Mach-Pascual S, Samii K, Beris P. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am J Hematol 1996;52:310-312.
17. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1997;89:3097-3103.
18. Pavlovsky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: prospective observations of an emerging syndrome. J Clin Apheresis 1997;12:159-164.
19. Chang JC, Shipstone A, Llenado-Lee MA. Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol 1996;53:11-17.
20. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982;307:1432-1435.
21. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996;87:4223-4234.
22. Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. Am J Med 1989;87:9N-15N.
23. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
24. Pereira A, Mazzara R, Monteagudo J, Sanz C, Puig L, Martinez A, Ordinas A, Castillo R. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 1995;70:319-323.
25. Asada Y, Sumiypshi A. Histopathology of thrombocytopenic purpura. Jpn J Clin Med 1993;51:159-162.
26. Shamseddine A, Chehal A, Usta I, Salem Z, El Saghir N, Taher A. Thrombotic thrombocytopenic purpura and pregnancy: report of 4 cases and literature review. J Clin Apheresis 2004;19:5-10.
27. Eldor A. Thrombotic Thrombocytopenic purpura: diagnosis, pathogenesis and modern therapy. Bailleres Cin Haematol 1998;11:475-495.
28. Harkness DR, Byrnes JJ, Lian EC, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981;246:1931-1933.
29. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977;297: 1386-1389.
30. Bukowski RM, King JW, Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413-417.
31. Ansell J, Beaser RS, Pechet L. thrombotic thrombocytopenic purpura fails to respond to fresh frozen plasma infusion. Ann Int Med 1978;89:647-648.
32. Aster RH. Plasma therapy for thrombotic thrombocytopenic purpura: sometimes it works, but why? N Engl J Med 1985; 312:985-987.
33. Smith JW, Weinstein R, Hillyer KL. Therapeutic Apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003;43:820-822.
34. Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T, Pappa M, Mellou S, Kostourou A, Papageorgiou E, Raptis SA. Thrombotic thrombocytopenic purpura/haemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 2000;79:66-72.
35. Lara PN, Coe TL, Zhou H, Fernando L, Holland PV, Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 1999;107:573-579.
36. Ramanan AS, Thirumala S, Chandrasekaran V. Thrombotic thrombocytopenic purpura: a single institution experience. J Clin Apheresis 1999;14:9-13.
37. Hayward CP, Sutton DM, Carter WH Jr, Cambell ED, Scott JG, Francombe WH, Shumak KH, Baker MA. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Int Med 1994;154: 982-987.